Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 24Gastrointestinal 14Genitourinary 13Other hematologic neoplasm 8Lymphoid 8Other 4Dermatologic 4Thoracic 3CNS 3Tumor-Agnostic 2Head & Neck 2Gynecologic 2Endocrine 2Plasma cell 1

Conditions

Multiple Endocrine Neoplasia Type 1 2Vitamin D Deficiency 1Osteoporosis 1Inflammation 1Bone Diseases, Metabolic 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vitamin D × Endocrine × Clear all
NCT03408119 2022-10-07

Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men

Florida State University

Phase NA Completed
62 enrolled
Endocrine

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

NCT01437696 2014-09-05

How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months?

McGill University

Phase 4 Completed
77 enrolled
Endocrine

Inflammation, Vitamin D Deficiency, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡